Abstract:OBJECTIVE To explore the characteristics and therapies of patients with acute myocardial infarction (AMI) in Wuxi city, China. METHODS A network was established to obtain information of patients with AMI who were admitted to 9 designated hospitals between 2011 and 2012. A total of 1 714 patients were enrolled (1 334 males, 754 smokers, 1 076 hypertension, 270 hyperlipidemia and 398 diabetes) including 1 410 patients with acute ST-segment elevation myocardial infarction (STEMI) and 304 patients with acute non ST-segment elevation myocardial infarction (NSTEMI). Patients' characteristics, therapies, the incidence of major adverse cardiovascular events (MACEs) and all-cause mortality were analyzed. RESULTS (1) Medication therapy was as follows: antiplatelet therapy 98.3% (1 685 cases) , beta-blockers 59.1% (1 013 cases) , ACEI or ARB 67.6% (1 159 cases) , statins 98.1% (1 682 cases) , and nitrates 71.1% (1 218 cases) . Of the patients, 7.1% (132 cases) received temporary pacemakers, 34.0% (480 cases) with acute STEMI underwent reperfusion [direct PCI 18.4% (260 cases) and thrombolysis 15.6% (220 cases)]. (2) According to the hospital admission data, patients were divided into three groups: group A, transported to the hospital by ambulance (n = 361); group B, transported to the hospital by private vehicles (n = 1 318); and group C, AMI occurred in the hospital (n = 35). The median time of AMI onset to physician contact of the 3 groups was 178 min, 368 min, and 9 min, respectively. The median time from AMI onset to the first ECG was 181 min, 379 min, and 10 min, respectively. The median time from AMI onset to cardiology specialist consultation was 187 min, 431 min, and 69 min, respectively. AMI onset-to-physician contact, AMI onset-to-first ECG, and AMI onset-to-specialized treatment time was the shortest in group C, followed by group A and group B. For patients with STEMI underwent reperfusion therapy, the median AMI onset-to-reperfusion therapy time was significantly shorter in group A patients than group B patients [thrombolysis group: 224(171, 514) min vs. 378 (158, 785) min, PCI group: 318 (154, 674) min vs. 489 (143, 816) min, all P < 0.05]. (3) The total incidence of MACEs was 16.3% (279/1 714), the all-cause in-hospital mortality rate was 13.1% (224/1 714). According to the AMI onset-to-physician contact, patients were divided into 4 groups: <3 h, 3-6 h, 6-12 h, and >12 h. The incidence of MACEs [4.4% (23/517), 13.3% (60/451), 19.1% (77/404) and 34.8% (119/342),χ(2) = 114.36, P < 0.01] and all-cause in-hospital mortality rate [4.1% (21/517) , 10.4% (47/451), 18.6% (75/404), 23.7% (81/342), χ(2) = 84.36, P < 0.01] increased in proportion to the time of AMI onset-to-physician contact. Among STEMI patients, the incidence of MACEs [5.8% (15/260) , 12.3% (27/220) , 20.9% (194/930) ,χ(2) = 39.93, P < 0.01] and all-cause in-hospital mortality [1.5% (4/260) , 10.0% (22/220) , 18.2% (170/930) ,χ(2) = 50.90, P < 0.01] was the lowest in the primary PCI group, followed by thrombolysis group and was the highest in the early conservative treatment group. CONCLUSIONS Guideline is well followed in terms of drug treatments of AMI in this cohort, but only a small proportion of AMI patients in Wuxi received reperfusion therapy. There is a considerable out-of-hospital time delay for AMI patients in this cohort which is shorter in group A than in group B. All-cause in-hospital mortality and MACEs is the lowest in AMI patients underwent primary PCI.

Chest Pain Centers Contribute To Decrease In Acute Cardiac Complications And Better Short-Term Prognosis For Patients With Ami

PCV85 EFFECT OF CHEST PAIN CENTER ON THE TREATMENT OF PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN TIANJIN, CHINA

Fibrinolytic Therapy Use for ST-segment Elevation Myocardial Infarction and Long-Term Outcomes in China: 2-Year Results from the China Acute Myocardial Infarction Registry

Clinical characteristics and in-hospital management strategies in patients with acute coronary syndrome: results from 2,096 accredited Chest Pain Centers in China from 2016 to 2021

Chest Pain Center Accreditation is Associated with Improved In‐Hospital Outcomes of Acute Myocardial Infarction Patients in China: Findings from the CCC‐ACS Project

Application of Remote Electrocardiogram Monitoring Systems in Chest Pain Centers for Patients with High-Risk Chest Pain.

Protocol of the China ST-segment Elevation Myocardial Infarction (STEMI) Care Project (CSCAP): a 10-Year Project to Improve Quality of Care by Building Up a Regional STEMI Care Network

Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1

Role of the Chest Pain Center in Treatment of Patients with Acute ST-elevated Myocardial Infarction

The impacts of the chest pain center accreditation on the efficacy of pre-hospital care in patients with ST-segment elevation myocardial infarction

Effectiveness of chest pain centre accreditation on the management of acute coronary syndrome: a retrospective study using a national database

Impact of chest pain center quality control indicators on mortality risk in ST-segment elevation myocardial infarction patients: a study based on Killip classification

Effect of continuous improvement of standardized construction of China Chest Pain Center on treatment time and mortality of acute ST-segment elevation myocardial infarction: A population-based study

Effect of quality control center of China chest pain center on chest pain management procedure impr-ovement in certificated chest pain center

The Impact of American College of Cardiology Chest Pain Center Accreditation on Guideline Recommended Acute Myocardial Infarction Management

Establishment of Chest Pain Center in Emergency Department of Hospital Can Shorten the Diagnosis-and-treatment Time for Patients with Acute Chest Pain

Timing of angiography and outcomes in patients with non-ST-segment elevation myocardial infarction: Insights from the evaluation and management of patients with acute chest pain in China registry

An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence

[A multi-center survey on the therapeutic status of patients with acute myocardial infarction in Wuxi city of China].

Regional Variations in Management and Outcomes of Patients with Acute Coronary Syndrome in China: Evidence from the National Chest Pain Center Program

Changes in Process and Outcome for ST Elevation Myocardial Infarction in Central China from 2011 to 2018.